Search
for
Sort by
Research 61–90 of 1000+
- What causes hidradenitis suppurativa ?—15 years after
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- COVID-19 and Sex Differences
- Modeling cell–cell communication for immune systems across space and time
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Immunomodulatory Effects of Platelet-Rich Plasma (PRP) on Neuroinflammation: Insights from B92 Glial Cells Stimulated with Heat-Killed Escherichia coli
- Chemical Constituents from Osmanthus fragrans var. aurantiacus Makino with Their In Vitro and In Silico Studies Target Anti-Inflammation by Suppressing ERK 1/2 MAPK Signaling
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- Immunomodulators in the treatment of cutaneous lymphoma
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Epidermal Notch1 recruits innate lymphoid cells to orchestrate normal skin repair
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Modern hair restoration surgery
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Tannic Acid Accelerates Cutaneous Wound Healing in Rats Via Activation of the <i>ERK 1/2</i> Signaling Pathways
- Inflammatory perifollicular fibrosis and alopecia
- Effect of <i>Ficus carica</i> leaf extract on the gene expression of selected factors in HaCaT cells
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis